MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer

We hypothesized that MAP kinase-interacting serine/threonine kinase 2 (MNK2) may contribute to non-small cell lung cancer (NSCLC) development, and serve as a new therapeutic target. Immunohistochemical staining evaluated the correlation between MNK2 expression and clinicopathological features in 367...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zhihua, Peng, Guilin, Li, Ermao, Xi, Shaoyan, Zhang, Yu, Li, Yong, Lin, Xiaodong, Li, Guangqiu, Wu, Qinian, He, Jianxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587555/
https://www.ncbi.nlm.nih.gov/pubmed/28878291
http://dx.doi.org/10.1038/s41598-017-10397-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587555/
https://www.ncbi.nlm.nih.gov/pubmed/28878291
http://dx.doi.org/10.1038/s41598-017-10397-9

Ejemplares similares